EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 3.0

Integrated Multi-Omics Approaches for Predicting Immune Checkpoint Inhibitor Response in NSCLC – Insights From Genomics, Proteomics, and Metabolomics

Eman Elayeh iD, Shereen M Aleidi, Orwa Aboud iD, Mohammad H Semreen iD, Yasser K Bustanji, Lina A Dahabiyeh

Lung Cancer: Targets and Therapy · 2025-12 · Volume 16 · 167-198

DOI: 10.2147/lctt.s539777 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Lung Cancer: Targets and Therapy, 2025-12. Verfasst von Eman Elayeh und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biopharmaceutics and Clinical Pharmacy, School of Pharmacy, The University of Jordan, Amman, 11942, Jordan. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 198 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

biomarkersimmune checkpoint inhibitorsmulti-omicsnon-small cell lung cancerprediction of response

Autor:innen und Institutionen

  • Department of Biopharmaceutics and Clinical Pharmacy, School of Pharmacy, The University of Jordan, Amman, 11942, Jordan.
  • Department of Medicinal Chemistry, College of Pharmacy, University of Sharjah, Sharjah, 27272, United Arab Emirates.
  • Department of Neurology, University of California, Davis, Sacramento, CA, 95817, USA.
  • Department of Neurological Surgery, University of California, Davis, Sacramento, CA, 95817, USA.
  • Comprehensive Cancer Center, University of California, Davis, Sacramento, CA, 95817, USA.
  • Research Institute of Medical and Health Sciences, University of Sharjah, Sharjah, United Arab Emirates.

ORCID-Profile: Eman Elayeh, Orwa Aboud, Mohammad H Semreen

Zitieren

APA

Elayeh, E., Aleidi, S. M., Aboud, O., Semreen, M. H., Bustanji, Y. K., & Dahabiyeh, L. A. (2025). Integrated Multi-Omics Approaches for Predicting Immune Checkpoint Inhibitor Response in NSCLC – Insights From Genomics, Proteomics, and Metabolomics. Lung Cancer: Targets and Therapy, Volume 16, 167-198. https://doi.org/10.2147/lctt.s539777

Vancouver

Elayeh E, Aleidi SM, Aboud O, Semreen MH, Bustanji YK, Dahabiyeh LA. Integrated Multi-Omics Approaches for Predicting Immune Checkpoint Inhibitor Response in NSCLC – Insights From Genomics, Proteomics, and Metabolomics. Lung Cancer: Targets and Therapy. 2025;Volume 16:167-198. doi:10.2147/lctt.s539777

BibTeX
@article{Elayeh2025,
  author = {Elayeh, Eman and Aleidi, Shereen M and Aboud, Orwa and Semreen, Mohammad H and Bustanji, Yasser K and Dahabiyeh, Lina A},
  title = {Integrated Multi-Omics Approaches for Predicting Immune Checkpoint Inhibitor Response in NSCLC – Insights From Genomics, Proteomics, and Metabolomics},
  journal = {Lung Cancer: Targets and Therapy},
  year = {2025},
  volume = {Volume 16},
  pages = {167--198},
  doi = {10.2147/lctt.s539777}
}
Kostenlos starten →